ANI Pharmaceuticals (ANIP)
(Real Time Quote from BATS)
$59.73 USD
-0.39 (-0.65%)
Updated Oct 18, 2024 01:26 PM ET
1-Strong Buy of 5 1
B Value C Growth F Momentum C VGM
ANI Pharmaceuticals (ANIP) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$79.00 | $94.00 | $60.00 | 31.40% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for ANI Pharmaceuticals comes to $79.00. The forecasts range from a low of $60.00 to a high of $94.00. The average price target represents an increase of 31.4% from the last closing price of $60.12.
Analyst Price Targets (6 )
Broker Rating
ANI Pharmaceuticals currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.60 a month ago based on five recommendations.
Of the six recommendations deriving the current ABR, four are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 66.67% and 16.67% of all recommendations. A month ago, Strong Buy made up 60%, while Buy represented 20%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.60 | 1.20 | 1.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/18/2024 | Raymond James | Gary Nachman | Moderate Buy | Moderate Buy |
9/11/2024 | Capital One Securities | Timothy Chiang | Strong Buy | Strong Buy |
9/11/2024 | Truist Securities | Leszek Sulewski | Strong Buy | Hold |
6/26/2024 | H.C. Wainwright & Co. | Oren Livnat | Strong Buy | Strong Buy |
3/5/2024 | Guggenheim Securities | Vamil Divan | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 6 |
Average Target Price | $79.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 88 of 252 |
Current Quarter EPS Est: | 1.07 |
ANIP FAQs
ANI Pharmaceuticals, Inc. (ANIP) currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for ANI Pharmaceuticals, Inc. (ANIP) is $79.00. The current on short-term price targets is based on 3 reports.
The forecasts for ANI Pharmaceuticals, Inc. (ANIP) range from a low of $60 to a high of $94. The average price target represents a increase of $31.40 from the last closing price of $60.12.
The current UPSIDE for ANI Pharmaceuticals, Inc. (ANIP) is 31.40%
Based on short-term price targets offered by six analysts, the average price target for ANI Pharmaceuticals comes to $79.00. The forecasts range from a low of $60.00 to a high of $94.00. The average price target represents an increase of 31.4% from the last closing price of $60.12.